ROPES WEALTH ADVISORS LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2020$97,000
-41.6%
2,648
-39.8%
0.02%
-53.1%
Q3 2020$166,000
-8.3%
4,398
-1.1%
0.03%
-13.5%
Q2 2020$181,000
+9.7%
4,448
+2.3%
0.04%
-11.9%
Q1 2020$165,000
-19.1%
4,3480.0%0.04%
-4.5%
Q4 2019$204,000
+42.7%
4,348
+29.9%
0.04%
+46.7%
Q3 2019$143,000
+6.7%
3,3480.0%0.03%
+7.1%
Q2 2019$134,000
-4.3%
3,3480.0%0.03%
-24.3%
Q1 2019$140,000
+33.3%
3,348
+21.8%
0.04%
+23.3%
Q4 2018$105,000
-4.5%
2,7480.0%0.03%
+11.1%
Q3 2018$110,000
-0.9%
2,7480.0%0.03%
-10.0%
Q2 2018$111,000
+3.7%
2,7480.0%0.03%
+3.4%
Q1 2018$107,000
+46.6%
2,748
+34.2%
0.03%
+52.6%
Q4 2017$73,000
-30.5%
2,048
-21.0%
0.02%
-32.1%
Q3 2017$105,000
-38.6%
2,594
-34.6%
0.03%
-41.7%
Q2 2017$171,000
+2.4%
3,9690.0%0.05%0.0%
Q1 2017$167,000
-1.2%
3,969
-9.8%
0.05%
-9.4%
Q4 2016$169,000
-11.1%
4,4000.0%0.05%
-17.2%
Q3 2016$190,000
-0.5%
4,4000.0%0.06%
-4.5%
Q2 2016$191,000
+18.6%
4,400
+10.9%
0.07%
-5.6%
Q1 2016$161,000
+0.6%
3,9690.0%0.07%
+1.4%
Q4 2015$160,000
-47.7%
3,969
-50.2%
0.07%
-56.2%
Q3 2015$306,000
+66.3%
7,969
+80.5%
0.16%
+60.0%
Q2 2015$184,000
-9.8%
4,4150.0%0.10%
-5.7%
Q1 2015$204,0004,4150.11%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders